Guanglai Li

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease

Peng Feng, Xiangjian Zhang, Dongfang Li et al. · Neuropharmacology · 2018 · 115 citations · Full text

Life Sciences, Neuroscience, Pharmacology +14

A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

Ziyue Yuan, Dongfang Li, Peng Feng et al. · European Journal of Pharmacology · 2017 · 107 citations · Full text

Medicine, Neuroscience, Pharmacology +16

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF

Chenhui Ji, Guofang Xue, Peng Feng et al. · Brain Research · 2015 · 98 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke

Xiaoyan Yang, Peng Feng, Xiangjian Zhang et al. · Neuropharmacology · 2019 · 94 citations

Life Sciences, Neuroscience, Pharmacology +17

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain

Dongfang Li, Peng Feng, Lin Li et al. · Neuroreport · 2016 · 92 citations

Life Sciences, Neuroscience, Pharmacology +17